/Investor DB

Dreamers VC — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Craifcraif.cominSeries C · Dec 2024 · $22M

Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.

AI & Machine LearningBiotechHealthtechMedical DevicesTokyo, JP

Ryuichi Onose(Founder)inYuki Ichikawa(Director)Mika Yui(Director)Ryuichi Onose Takao Yasui(Founder)

Co-investors1955 CapitalGlobal BrainHakuhodo DY VenturesSaisei VenturesAozora Corporate Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.